Skip to main content

Table 1 Basic characteristics of the patients

From: Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes

Age (years) 48.2 ± 10.7
Gender (male/female) 10/10
Body weight (kg) 91.7 ± 22.3
Body mass index (kg/m2) 33.0 ± 4.9
Systolic blood pressure (mmHg) 128.5 ± 11.0
Diastolic blood pressure (mmHg) 74.4 ± 10.4
BUN (mg/dL) 13.0 ± 3.9
Creatinine (mg/dL) 0.63 ± 0.16
HbA1c (%) 9.2 ± 1.4
Medication
 Anti-hypertensive agents (%) 11 (55%)
 Lipid-regulating agents (%) 10 (50%)
 Oral anti-diabetic agents (%) 19 (95%)
 Insulin (%) 10 (50%)
  1. BUN blood urea nitrogen; HbA1c glycosylated hemoglobin